- Open Access
Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran
© Doosti and Mokhtari-Farsani; licensee BioMed Central Ltd. 2014
- Received: 21 April 2014
- Accepted: 27 May 2014
- Published: 5 June 2014
Clostridium difficile (C. difficile) is a gram-positive, toxin-producing bacillus which is an intestinal pathogen in both humans and animals and causes a range of digestive disorders including inflammation of the bowel, abdominal pain, fever and diarrhea. C. difficile toxins include enterotoxin (Toxin A), cytotoxin (Toxin B) and a binary toxin. Two large protein toxins A and B are encoded by separate genes, tcdA and tcdB. Clostridium difficile infection (CDI) mainly caused by the activity of the genes tcdA and tcdB. The binary toxin is encoded by the genes cdtA and cdtB. The binary toxin caused increased adherence of bacteria to intestinal epithelium. The aim of the present study was isolation of C. difficile from feces of calves, and study of the frequency of C. difficile virulence genes.
150 samples of fresh feces from calves were collected and C. difficile was isolated from feces of calves using bacterial culture methods. DNA was extracted by a genomic DNA purification kit. Then PCR method was used for definitive diagnosis of C. difficile. Multiplex PCR method performed for identification of tcdA, tcdB, cdtA and cdtB genes. In the final stage antimicrobial resistance determining was carried out by standard Bauer-Kirby disk diffusion method.
C. difficile was isolated from 90 samples (60%). The tcdA was observed in 8 isolates (8.8%), tcdB in 16 isolates (17.7%), cdtA in 8 isolates (8.8%) and cdtB in 14 isolates (15.5%). Only 1 isolated (1.1%) was containing all four genes tcdA, tcdB, cdtA and cdtB, 2 isolates (2.2%) only had both tcdA and tcdB genes, and there was no sample positive only for both cdtA and cdtB. The highest rate of drug resistance was against clindamycin (100%) and the highest rate of drug sensitivity was against ciprofloxacin (50%).
The results showed high incidence of C. difficile and also high antibiotic resistance of this bacterium, but frequency of strains containing virulence genes (tcdA, tcdB, cdtA and cdtB) was low.
- Clostridium difficile
- Toxin A
- Toxin B
- Binary toxin
Clostridium difficile (C. difficile) is a gram-positive, spore-forming, anaerobic, toxin-producing bacillus, catalase-negative bacterium and is part of the normal gut flora in less than 5% of humans that can infect both humans and animals. C. difficile there at everywhere in the environment and as well as exist as free-living bacteria that it has been found in farm animals, pets, on various surfaces in hospitals and in foods such as vegetables, meats, water and soil. It is transmitted via the fecal–oral route among humans and also is transmitted to humans from animals and animal products. Clostridium difficile infection (CDI) is a global problem that is caused by the ingestion of vegetative organisms and spores, most likely the latter which survive exposure to gastric acidity and germinate in the colon. C. difficile recognized as a major nosocomial pathogen responsible for 15-20% of antibiotic-related diarrhea and is the etiologic agent of perforation of the colon, pseudomembranous colitis or toxic megacolon and even death in humans[3, 4]. C. difficile also is an important factor for of enteric disease in other species, including calves (10.2%), cows, ostriches, horses, pigs, rabbits, cats and dogs[5, 6]. The symptoms of CDI in both humans and animal include inflammation of the bowel, abdominal pain, fever and diarrhea. Recently, research has suggested that the frequency, relapse, and severity of Clostridium difficile associated diseases (CDAD) are increasing in North America and Europe and also per year 2012, United States health care expenses associated with treating CDAD are estimated about $3.2 billion. C. difficile toxins include toxin A, toxin B and a binary toxin. Toxins A (enterotoxin) and B (cytotoxin) (308 kDa and 270 kDa, respectively), are encoded by two separate genes, tcdA and tcdB which are located in a 19.6-kb pathogenicity locus (PaLoc) and are responsible for the symptoms of CDAD and also includes the positive and negative regulators tcdR and tcdC. They are structurally similar to each other, but toxin B is generally more robust (~1000 fold) than toxin A. The binary toxin is encoded by the genes cdtA and cdtB located outside PaLoc, which these two genes form another operon with cdtR (cdtR is a positive regulator). C. difficile toxins directly affect the colon epithelial cells, and immune cells are forced to produce chemokines and cytokines. Standard treatment for CDI in both humans and animals is use of the vancomycin or metronidazole which neither of these antibiotics is not fully effective, but new therapeutic options include the use of new antibiotics, probiotics, toxin-absorbing polymer, monoclonal antibodies, fecal treansplant, toxoid vaccines and Intravenous immunoglobulin (IVIG). To our knowledge, there are no many studies on C. difficile in feces calves in around the world and also there are no study on C. difficile in feces calves in Iran; thus, the purpose of present study was isolation of C. difficile from feces of calves from Chaharmahal va Bakhtiari province in south west of Iran using bacterial culture methods, and study of the frequency of C. difficile tcdA, tcdB, cdtA and cdtB genes using Multiplex PCR method, and also study of antibiotic resistance in this bacterium.
In this cross-sectional descriptive study, a total one hundred fifty (150) samples of fresh feces from calves with age 3 to 25 days in autumn of 2013 were collected from industrial and indigenous calves farms in Chaharmahal va Bakhtiari province (southwest of Iran). Only one stool sample was collected from each calf. Feces were collected from animals rectum using the new clean gloves and about 3 g of the sample was transferred to a new sterile Tube and were transported to the laboratory immediately in an insulating foam box with ice.
C. difficile Culture
DNA extraction and PCR
C. difficile was grown on blood agar for 48 h and approximately 3 colonies were suspended in 100 μL of sterile ultrapure deionized water and DNA was extracted by a genomic DNA purification kit (CinnaGen Co, Iran) according to the manufacturer’s instructions. The total DNA was measured at 260 nm optical density according to the method described by Sambrook and Russell (2001). DNA samples were stored at −20°C until they were used. Polymerase chain reaction (PCR) method was used for definitive diagnosis of C.difficile. Detection of C. difficile was performed by amplification with the following primers: C.D-F: 5’-CCTCCTCAAGTACCGTCATTATC-3’ and C.D-R: 5’-CAAAGGTGAGCCAGTACAG GA-3’ [Gene Bank: NC_009089 ]. The primers were design from 16S ribosomal RNA (16S rRNA) gene of C. difficile using Gene Runner software (Version 3.01) and at the NCBI using the experimental GENINFO BLAST Network Service to assess degree of homology between these primers and other reported sequences and at the end were obtained from CinnaGen Co, Iran. PCR reactions were performed in a total volume of 25 μL in 0.2 ml tubes containing 2 μL of DNA sample, 1 μM of each primers, 2 mM MgCl2 , 5 μL of 10X PCR buffer AMS, 200 μM dNTPs and 1 unit of Taq DNA polymerase (CinnaGen Co, Iran). The PCR assay was performed at 95°C for 5 min and then for 32 cycles of 94°C for 1 min, 61°C for 40 sec, 72°C for 40 sec, and a final extension at 72°C for 5 min, with a final hold at 10°C in a thermal cycler (Mastercycler gradient, Eppendrof, Germany).
Detection of PCR products
The PCR-amplified products (C.D 16S rRNA, 264 bp) were detected in 1.5% ethidium bromide (EtBr)-stained agarose gel electrophoresis. Constant voltage of 84 V for 25 min was used for products separation. The DNA molecular weight marker (100 bp, Fermentas, Germany) was used as a size marker. The gel viewed on UV transilluminator and photographed were obtained in UVI doc gel documentation systems (UK).
Multiplex PCR for identification of tcdA, tcdB, cdtA and cdtB genes
Primers for identification of C. difficile tcdA, tcdB, cdtA and cdtB genes
Amplicon size (bp)
Antimicrobial drug susceptibility tests
Drug resistance testing using standard Bauer-Kirby disk diffusion method for all samples (positive culture) was performed. A total of 5 antibiotic discs (Padtanteb, Iran) with tetracycline, ciprofloxacin, clindamycin, erythromycin and vancomycin were used. These antimicrobial agents were chosen on the basis of their importance in treating humans or animals CDI. Diameters of the inhibition zones were interpreted based on the NCCLS subcommittee’s recommendations.
All data were analyzed by using MS Excel 2007 and SPSS software (Version 17.SPSS Inc, USA) and p value was calculated using Chi-square and Fisher’s exact tests to find any significant relationship. P value less than 0.05 was considered statistically significant.
The frequency of C. difficile and virulence genes
Antibiogram profile of the 90 C. difficile isolates from feces of calves
No. of samples positive
% of samples positive
No. of samples positive
% of samples positive
No. of samples positive
% of samples positive
Ciprofloxacin (5 μg)
Erythromycin (15 μg)
Clindamycin (2 μg)
Tetracycline (30 μg)
Vancomycin (2 μg)
C. difficile was recognized as an intestinal pathogen in the late 70th of twentieth century. C. difficile is agent for more than 95% of cases of pseudomembranous colitis and 15–25% of cases of antibiotic-associated diarrhea. CDAD in humans may have an animal origin, for example, C. difficile is found in market meat, and studies have shown that Pathogenic strains in humans and animals especially calves, are very similar. In recent years, has emerged changes in the epidemiology of CDAD in humans and also CDI is increasing in prevalence, severity and mortality. Development of antibiotic resistance in C. difficile serotypes has been considered as a public health problem throughout the world. It seems that in order to determine the epidemiology of C. difficile- associated disease should studies and more research be done around the world. In present study was observed a relatively high prevalence of C. difficile and virulence genes, and also isolates showed high percentage of resistance against antibiotics. The study of Arroyo et al. showed that C. difficile isolated from calves are carrier the genes encoding toxins A and B. In Rodriguez-Palacio et al. investigation in Canada, contamination rate with C. difficile in calves with a mean age of 14.2 days, 11.2% was reported, also examined C. difficile ribotypes, which 7 of 8 ribotype were common between humans and calves, furthermore, in antibiotic susceptibility testing, all isolates were sensitive to vancomycin, which is somewhat similar to the present study results. In Pirs et al. investigation, C. difficile was isolated from 1/56 calf samples (1.8%). The study of Janvilisri et al. showed that only 9 (52.9%) of the 17 calves were positive to C. difficile and every 9 positive samples were possessed the binary toxin, which is somewhat similar to the present study results. Hoffer et al. in Switzerland, announced Low occurrence of C. difficile in stool of calves, that C. difficile was isolated from only one fecal sample of a calf, furthermore, was determined that sample isolated is containing toxin A, toxin B and binary toxin. In Rodriguez et al. investigation in Belgium, prevalence of C. difficile was reported in calves on the farms 22.2%. Zidaric et al. found that the peak incidence of C. difficile in calves is in age 18 days (16%), also was found that the isolates were resistant to erythromycin, which is similar to the present study results.
The above data indicate that in around the world there are different rate of frequency of C. difficile and virulence genes of this bacterium. Furthermore, with review previous studies will be determined that there are different patterns of antimicrobial resistance of C. difficile isolated of different parts of the world. Our study and other studies throughout the world show that in recent years prevalence of pathogenic strains and resistant to antimicrobial drugs with speed is on the rise. Considering that, there aren’t large studies on virulence genes of C. difficile isolated from calves and domestic animals, the prevalence of these genes cannot be examined, but considering that amount of pathogenicity of C. difficile in worldwide is rising can be said that the prevalence of pathogenic strains that are containing these genes is on the rise. In the present study it was determined that ciprofloxacin is the best antibiotic for infections treatment caused by C. difficile and although there was a high rate of sensitivity to vancomycin, but resistance rate to this antibiotic was 80%. Nonetheless, examining antibiotic resistance patterns in other studies indicate that vancomycin is currently the best antibiotic for infections treatment caused by C. difficile in calves and other domestic animals, that is inconsistent with the results of our study.
In conclusion, our data show high prevalence of C. difficile in feces of calves in south west of Iran, that fortunately frequency of pathogenic strains (containing virulence genes) was low. On the other hand, our studies showed a high percentage of antibiotic resistance in the C. difficile which is a result of the indiscriminate use of antibiotics. Thus, given that many of C. difficile strains are common between humans and domestic animals and given the increasing importance of CDI in public health, we suggest further studies for recognition the epidemiology and detect any changes in resistance pattern, new therapies, restricting use of antimicrobial drugs in human and animals, performing antimicrobial susceptibility tests to select suitable antimicrobial agent, application of recommended dosage of antibiotic and following duration of therapy can help to decrease developing of resistant strains and pathogenic.
The authors gratefully acknowledge all the staff of Biotechnology Research Center of Islamic Azad University of Shahrekord Branch in southwest Iran for their sincere support.
- Hammond EN, Donkor ES: Antibacterial effect of Manuka honey on Clostridium difficile . BMC Res Notes 2013, 6: 1-5. 10.1186/1756-0500-6-1View ArticleGoogle Scholar
- Rogers MAM, Greene MT, Saint S, Chenoweth CE, Malani PN, Trivedi I, Aronoff DM: Higher Rates of Clostridium difficile Infection among Smokers. Plos one 2012, 7: e42091. 10.1371/journal.pone.0042091PubMedPubMed CentralView ArticleGoogle Scholar
- Janvilisri T, Scaria J, Chang YF: Transcriptional profiling of Clostridium difficile and Caco-2 cells during infection. J Infect Dis 2010, 202: 282-290. 10.1086/653484PubMedPubMed CentralView ArticleGoogle Scholar
- Hung YP, Tsai PJ, Hung KH, Liu HC, Lee CI, Lin HJ, Wu YH, Wu JJ, Ko WC: Impact of Toxigenic Clostridium difficile Colonization and Infection among Hospitalized Adults at a District Hospital in Southern Taiwan. Plos one 2012, 7: e42415. 10.1371/journal.pone.0042415PubMedPubMed CentralView ArticleGoogle Scholar
- Rodriguez-Palacios A, Stämpfli HR, Duffield T, Peregrine AS, Trotz-Williams LA, Arroyo LG, Brazier JS, Weese JS: Clostridium difficile PCR Ribotypes in Calves, Canada. Emerging Infect Dis 2006, 12: 1730-1736. 10.3201/eid1211.051581PubMedPubMed CentralView ArticleGoogle Scholar
- Pirs T, Ocepek M, Rupnik M: Isolation of Clostridium difficile from food animals in Slovenia. J Med Microbiol 2008, 57: 790-792. 10.1099/jmm.0.47669-0PubMedView ArticleGoogle Scholar
- Davies NL, Compson JE, MacKenzie B, O’Dowd VL, Oxbrow AKF, Heads JT, Turner A, Sarkar K, Dugdale SL, Jairaj M, Christodoulou L, Knight DE, Cross AS, Hervé KJ, Tyson KL, Hailu H, Doyle CB, Ellis M, Kriek M, Cox M, Page MJ, Moore AR, Lightwood DJ, Humphreys DP: A Mixture of Functionally Oligoclonal Humanized Monoclonal Antibodies That Neutralize Clostridium difficile TcdA and TcdB with High Levels of In Vitro Potency Shows In Vivo Protection in a Hamster Infection Model. Clin Vaccine Immunol 2013, 20: 377-390. 10.1128/CVI.00625-12PubMedPubMed CentralView ArticleGoogle Scholar
- Swett R, Cisneros GA, Feig AL: Conformational Analysis of Clostridium difficile Toxin B and Its Implications for Substrate Recognition. Plos one 2012, 7: e41518. 10.1371/journal.pone.0041518PubMedPubMed CentralView ArticleGoogle Scholar
- Persson S, Jensen JN, Olsen KEP: Multiplex PCR Method for Detection of Clostridium difficile tcdA , tcdB , cdtA , and cdtB and Internal In-Frame Deletion of tcdC. J Clin Microbiol 2011, 49: 4299-4300. 10.1128/JCM.05161-11PubMedPubMed CentralView ArticleGoogle Scholar
- Sun X, Savidge T, Feng H: The Enterotoxicity of Clostridium difficile Toxins. Toxins 2010, 2: 1848-1880. 10.3390/toxins2071848PubMedPubMed CentralView ArticleGoogle Scholar
- National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing. In Twelfth Informational Supplement. Wayne: NCCLS document M100-S12 22, NCCLS; 2002:42.Google Scholar
- Lemee L, Dhalluin A, Testelin S, Mattrat MA, Maillard K, Lemeland JF, Pons JL: Multiplex PCR Targeting tpi (Triose Phosphate Isomerase), tcdA (Toxin A), and tcdB (Toxin B) Genes for Toxigenic Culture of Clostridium difficile . J Clin Microbiol 2004, 42: 5710-5714. 10.1128/JCM.42.12.5710-5714.2004PubMedPubMed CentralView ArticleGoogle Scholar
- Sadeghifard N, Salari MH, Ranjbar R, Ghafouryan S, Raftari M, Abdulamir AS, Fatimah AB, Kazemi B: The clinical and environmental spread and diversity of toxigenic Clostridium difficile diarrhea in the region of the Middle East. Reviews in Infect 2010, 1: 180-187.Google Scholar
- Arroyo LG, Kruth SA, Willey BM, Staempfli HR, Low DE, Weese JS: PCR ribotyping of Clostridium difficile isolates originating from human and animal sources. J Med Microbiol 2005, 54: 163-166. 10.1099/jmm.0.45805-0PubMedView ArticleGoogle Scholar
- Janvilisri T, Scaria J, Thompson AD, Nicholson A, Limbago BM, Arroyo LG, Songer JG, Grohn YT, Chang YF: Microarray Identification of Clostridium difficile Core Components and Divergent Regions Associated with Host Origin. J Bacteriol 2009, 191: 3881-3891. 10.1128/JB.00222-09PubMedPubMed CentralView ArticleGoogle Scholar
- Hoffer E, Haechler H, Frei R, Stephan R: Low occurrence of Clostridium difficile in fecal samples of healthy calves and pigs at slaughter and in minced meat in Switzerland. J Food Prot 2010, 73: 973-975.PubMedGoogle Scholar
- Rodriguez C, Taminiau B, Van Broeck J, Avesani V, Delmée M, Daube G: Clostridium difficile in young farm animals and slaughter animals in Belgium. J. Anaerobe 2012, 18: 621-625. 10.1016/j.anaerobe.2012.09.008View ArticleGoogle Scholar
- Zidaric V, Pardon B, Dos Vultos T, Deprez P, Brouwer MS, Roberts AP, Henriques AO, Rupnik M: Different antibiotic resistance and sporulation properties within multiclonal Clostridium difficile PCR ribotypes 078, 126, and 033 in a single calf farm. Appl Environ Microbiol 2012, 78: 8515-8522. 10.1128/AEM.02185-12PubMedPubMed CentralView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.